524558 Share Price Performance
₹18,108.65
4321.35 (31.34%)
3.5% overvalued intrinsic discount
₹17,494.50
Fair Value
Price ₹18,108.65
AnalystConsensusTarget ₹17,494.50
Fair Value₹17,494.50
Share Pricen/a
Neuland Laboratories Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
524558 Community Narratives
AN
Fair Value ₹17.49k 3.5% overvalued intrinsic discount
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
Key Takeaways Expansion of manufacturing capacity and complex API focus will enhance revenue momentum, margins, and client acquisition as industry shifts supply chains away from traditional sources. Investments in advanced manufacturing, site expansion, and automation are set to improve cost efficiencies, working capital, and global competitiveness.Read more
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
₹17.49k
3.5% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
30.81% p.a.
Profit Margin
23.2%
Future PE
43.54x
Share price in 2028
₹23.4k
Snowflake Analysis
Neuland Laboratories Limited Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 187.18
- 50.44%
- 15.66%
- 9.9%
About 524558
- Founded
- 1984
- Employees
- 1794
- CEO
- WebsiteView website
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
